Laila Arash‐Kaps

A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: One-year results

Melissa Wasserstein, Robin Lachmann, Carla E. M. Hollak et al. · Genetics in Medicine · 2022 · 91 citations · Full text

Trial of <i>N</i> -Acetyl- <scp>l</scp> -Leucine in Niemann–Pick Disease Type C

Tatiana Brémovà-Ertl, Uma Ramaswami, Marion M. Brands et al. · New England Journal of Medicine · 2024 · 82 citations

Pharmacokinetics, pharmacodynamics, and safety of moss‐aGalactosidase A in patients with Fabry disease

Julia B. Hennermann, Laila Arash‐Kaps, György Fekete et al. · Journal of Inherited Metabolic Disease · 2019 · 63 citations · Full text

Impact of immunosuppressive therapy on therapy‐neutralizing antibodies in transplanted patients with Fabry disease

Malte Lenders, Daniel Oder, Albina Nowak et al. · Journal of Internal Medicine · 2017 · 43 citations · Full text

The Clinical and Molecular Spectrum of GM1 Gangliosidosis

Laila Arash‐Kaps, Katalin Komlósi, Marlene Seegräber et al. · The Journal of Pediatrics · 2019 · 35 citations

Histopathology, Pathology, General Pathology +5